Our findings indicate that silmitasertib induces a deep change in the endocytic pathway of CRC cells, where large acidic LC3-II−/LAMP1+/Rab7+ macropinosomes are massively formed (see Fig. 8). The gene discussed is LAMP1; the disease is colorectal carcinoma.